Search results :

Terbinafine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: D01AE15, D01BA02

Side effects

Options: Show MedDRA Preferred Terms,   display all 22 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Abdominal cramps very common x x x
Anorexia very common x x x x x x x
Eructation very common x x x
Gastritis very common, 2.2% - 22% x x x x x x x
Abdominal discomfort very common x x x
Appetite absent very common x x x x x x
Nasopharyngitis 10% - 11% x
Headache common, 0.2% - 12.9% 0% - 9.5% x x x x x x x x x x x x x x x x x
Cough 5% - 6% x
Cramp muscle 1% - 10% x x x x
Erythema common, 0.9% - 9% x x x x x x x
Upper respiratory tract infection 5% x
Abdominal pain upper 4% x
Diarrhoea very common, 0% - 10% 0% - 2.9% x x x x x x x x x x x x x x x x x x
Dyspepsia very common, 0% - 22% 0% - 2.9% x x x x x x x x x x x x x x x x x x
Dizziness very rare, common x x x x x
Nausea very common, 0% - 11% 0% - 2.9% x x x x x x x x x x x x x x x x x
Flatulence very common, 0% - 2.2% 0% - 2.2% x x x x x x x x x x x x
Rash common, 0.7% - 9% 0.7% - 2.2% x x x x x x x x x x x x x x x x x x
Pharyngolaryngeal pain 2% x
Skin disorder 1.9% x
Abdominal pain 0% - 2.4% 0% - 1.5% x x x x x x x x x x x x x x x
Influenza 1% - 2% x
Nasal congestion 1% - 2% x
Pruritus common, 0% - 4% 0% - 1.5% x x x x x x x x x x x x x x x x x x x x
Toothache 1% x
Skin exfoliation 1% x x
Rhinorrhoea 0% - 2% x
Visual disturbance 0% - 1.5% 0% - 1.5% x x x x x x x x x
Rash erythematous 0.9% x
Urticaria common, 0% - 5% 0% x x x x x x x x x x x x x x x x x x
Vomiting postmarketing — 1.1% - 11% x x x x x x x x x x x x x x x x x x
Eczema 0.1% - 1% x x x x
Hypoglycaemia 0.1% - 1% x x x x
Pain 0.1% - 1% x x x x
Dry mouth 0.1% - 1% x x x x
Sickness 0.1% - 1% x x x x
Hepatic enzyme increased 0.1% - 1% x x x x
Agranulocytosis very rare, postmarketing x x x x x x x x x x x x x x x x x x
Alopecia postmarketing x x x x x x x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x x x x x x x x
Anaemia postmarketing x x x x x x x x x x x x
Angioedema very rare, postmarketing x x x x x x x x x x x x x x x x x x
Anosmia postmarketing x x x x x x x x x x
Anxiety postmarketing x x x x
Arthralgia postmarketing, very common x x x x x x x x x x x x x x x x x x
Mental disorder postmarketing x x x
Cholestasis postmarketing x x
Connective tissue disorder postmarketing x x x x x
Dermatitis exfoliative postmarketing x x x
Dysgeusia postmarketing — 0% - 2.8% 0% - 0.7% x x x x x x x x x x x x
Eosinophilia postmarketing x x x
Toxic epidermal necrolysis postmarketing x x x x x x x x x x x x x x
Erythema multiforme postmarketing x x x x x x x x x
Eye disorder postmarketing x x x
Fatigue very rare — 0.3% - 3% x x x x x x x x x x x x x x x x x x
Body temperature increased postmarketing, 6% - 7% x x x x x x x x x x
Gastrointestinal disorder postmarketing x x x x
Hepatitis postmarketing x x
Hypersensitivity postmarketing x x x x x x x x x x x x x x x x
Hypoaesthesia very rare — uncommon x x x x x x x
Immune system disorder postmarketing x x x x
Jaundice cholestatic rare x x x
Systemic lupus erythematosus very rare, postmarketing x x x x x x x x x x x x x x x x
Nervous system disorder postmarketing x x x x x
Neutropenia very rare, postmarketing x x x x x x x x x x x x x x x x x x
Pancreatitis postmarketing x x x x x x x x x x
Pancytopenia very rare, postmarketing x x x x x x x x x x x x x x
Paraesthesia very rare — uncommon x x x x x x x
Rhabdomyolysis postmarketing x x x x x x x x x x x x
Scotoma postmarketing x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x
Thrombocytopenia very rare, postmarketing x x x x x x x x x x x x x x x x x x
Tinnitus postmarketing x x x x x x
Angiopathy postmarketing x x x x x
Vasculitis postmarketing x x x x x x x x x
Vertigo postmarketing x x x x
Weight decreased postmarketing x x x x x x x x x x x x x x x x x
Hepatic failure very rare — rare x x x x x x x x x x x x x x x x x x
Dermatitis bullous postmarketing x x x
Depressive symptom postmarketing x x x x x x x x x
Liver injury postmarketing x x x x x x x x x x x
Photosensitivity reaction postmarketing x x x x x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x
Serum sickness-like reaction postmarketing x x x x x x x x x x
Malaise postmarketing x x x x x x x x x x x x x x x
Myalgia postmarketing, very common x x x x x x x x x x x x x x x x x x
Visual acuity reduced postmarketing x x x x x x x x
Psoriasis flare-up very rare, postmarketing x x x x x x x x x x x x x x x
Dermatitis psoriasiform postmarketing x x x x x x x x x x x x
Hepatobiliary disease postmarketing x x x x
Influenza like illness postmarketing x x x x x x x x x x
Blood and lymphatic system disorders postmarketing x x x x x
Ear and labyrinth disorders postmarketing x x x
Blood creatine phosphokinase increased postmarketing x x x x x x x x x x
Vasculitis gastrointestinal postmarketing x
Acute generalised exanthematous pustulosis postmarketing x x x x x x x x x x x x x x x
Hearing impaired postmarketing x x x x x x
Ageusia postmarketing — common x x x x x x x x x x x x x x x x x x
Chest pain very rare x x x
Blood disorder very rare x x x x x x x
Lightheadedness very rare x x x
Eruption very rare x x x
Anaphylactoid reaction very rare x x x x
Arthritis x x x x
Infection x x
Confusional state x
Drug eruption x
Dermatitis contact x
Ear disorder x x
Partial hearing loss x x
Jaundice x x x x
Liver disorder x x x x
Polymorphic light eruption x
Thrombotic thrombocytopenic purpura x x x x
Serum sickness x x x x
Hepatic function abnormal x x x x
Skin discolouration x
Hypogeusia x
Skin hyperpigmentation x
Fatal outcomes x x
Decreased appetite x
Bullous eruption x
Photosensitivity allergic reaction x
Redness x
Vision blurred x
Photosensitivity x x x x
Lupus erythematosus x x
Gastrointestinal symptom NOS x x x x x x x x x x
Rash generalised x
Toxic skin eruption x
Stinging x
Haematocrit decreased x
Infestation NOS x
Serum urea increased x x
Photodermatosis x
Hyposmia x x x
Visual impairment x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

TERBINAFINE / LAMISIL

Side effects:6
Source:FDA

terbinafine hydrochloride / Lamisil

Side effects:29
Source:FDA

TERBINAFINE

Side effects:32
Source:FDA Structured Product Label

Terbinafine

Side effects:32
Source:FDA Structured Product Label

TERBINAFINE

Side effects:32
Source:FDA Structured Product Label

TERBINAFINE

Side effects:47
Source:FDA Structured Product Label

TERBINAFINE

Side effects:47
Source:FDA Structured Product Label

Terbinafine

Side effects:48
Source:FDA Structured Product Label

TERBINAFINE

Side effects:48
Source:FDA Structured Product Label

TERBINAFINE

Side effects:51
Source:FDA Structured Product Label

TERBINAFINE HYDROCHLORIDE / LAMISIL SPRAY

Side effects:61
Source:Health Canada

Terbinafine hydrochloride / Tinasil

Side effects:63
Source:medicines.org.au

TERBINAFINE

Side effects:70
Source:FDA Structured Product Label

Terbinafine (as hydrochloride) / TERBINAFINE

Side effects:72
Source:medicines.org.au

TERBINAFINE

Side effects:80
Source:FDA Structured Product Label

terbinafine hydrochloride / LAMISIL TABLETS

Side effects:83
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label